These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11210672)

  • 1. Scaling up feasibility of the production of solid lipid nanoparticles (SLN).
    Gohla SH; Dingler A
    Pharmazie; 2001 Jan; 56(1):61-3. PubMed ID: 11210672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of solid lipid nanoparticles (SLN): scaling up feasibilities.
    Dingler A; Gohla S
    J Microencapsul; 2002; 19(1):11-6. PubMed ID: 11811752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A
    Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of solid lipid nanoparticles with respect to particle size distribution and drug loading.
    Patravale VB; Ambarkhane AV
    Pharmazie; 2003 Jun; 58(6):392-5. PubMed ID: 12857001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured lipid carriers as novel carrier for sunscreen formulations.
    Xia Q; Saupe A; Müller RH; Souto EB
    Int J Cosmet Sci; 2007 Dec; 29(6):473-82. PubMed ID: 18489386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation of tetrandrine solid lipid nanoparticles].
    Li YC; Dong L; Jia A; Chang XM; Xue H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):686-9. PubMed ID: 17121232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
    Saupe A; Wissing SA; Lenk A; Schmidt C; Müller RH
    Biomed Mater Eng; 2005; 15(5):393-402. PubMed ID: 16179760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
    Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
    Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of solid lipid nanoparticles loaded with traditional Chinese medicine by high-pressure homogenization.
    Li YC; Dong L; Jia A; Chang XM; Xue H
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):541-4. PubMed ID: 16762843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.
    Radomska-Soukharev A; Müller RH
    Pharmazie; 2006 May; 61(5):425-30. PubMed ID: 16724540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin moisturizing effect and skin penetration of ascorbyl palmitate entrapped in solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) incorporated into hydrogel.
    Uner M; Wissing SA; Yener G; Müller RH
    Pharmazie; 2005 Oct; 60(10):751-5. PubMed ID: 16259122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid and semisolid SLN dispersions for topical application: rheological characterization.
    Lippacher A; Müller RH; Mäder K
    Eur J Pharm Biopharm; 2004 Nov; 58(3):561-7. PubMed ID: 15451530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations.
    Souto EB; Wissing SA; Barbosa CM; Müller RH
    Eur J Pharm Biopharm; 2004 Jul; 58(1):83-90. PubMed ID: 15207541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimization preparation of chansu-loaded solid lipid nanoparticles by central composite design and response surface method].
    Yang Y; Feng JF; Zhang H; Luo JY
    Zhongguo Zhong Yao Za Zhi; 2006 Apr; 31(8):650-3. PubMed ID: 16830822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.
    Müller RH; Maassen S; Weyhers H; Mehnert W
    J Drug Target; 1996; 4(3):161-70. PubMed ID: 8959488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN).
    Souto EB; Anselmi C; Centini M; Müller RH
    Int J Pharm; 2005 May; 295(1-2):261-8. PubMed ID: 15848010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
    Souto EB; Wissing SA; Barbosa CM; Müller RH
    Int J Pharm; 2004 Jun; 278(1):71-7. PubMed ID: 15158950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA; Kayser O; Müller RH
    Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.